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Abstract
Background: As stem cells of the early embryo mature and differentiate into all tissues, the mitochondrial complement
undergoes dramatic functional improvement. Mitochondrial activity is low to minimize generation of DNA-damaging
reactive oxygen species during pre-implantation development and increases following implantation and differentiation to
meet higher metabolic demands. It has recently been reported that when the stem cell type known as induced pluripotent
stem cells (IPSCs) are re-differentiated for several weeks in vitro, the mitochondrial complement progressively re-acquires
properties approximating input fibroblasts, suggesting that despite the observation that IPSC conversion ‘‘resets’’ some
parameters of cellular aging such as telomere length, it may have little impact on other age-affected cellular systems such as
mitochondria in IPSC-derived cells.
Methodology/Principal Findings: We have examined the properties of mitochondria in two fibroblast lines, corresponding
IPSCs, and fibroblasts re-derived from IPSCs using biochemical methods and electron microscopy, and found a dramatic
improvement in the quality and function of the mitochondrial complement of the re-derived fibroblasts compared to input
fibroblasts. This observation likely stems from two aspects of our experimental design: 1) that the input cell lines used were
of advanced cellular age and contained an inefficient mitochondrial complement, and 2) the re-derived fibroblasts were
produced using an extensive differentiation regimen that may more closely mimic the degree of growth and maturation
found in a developing mammal.
Conclusions/Significance: These results — coupled with earlier data from our laboratory — suggest that IPSC conversion
not only resets the ‘‘biological clock’’, but can also rejuvenate the energetic capacity of derived cells.
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Introduction
Induced pluripotent stem cells (IPSCs) are emerging as an
important new tool to model human disease with potential to be
used one day in the treatment of these same disorders. With regard
to cell replacement, IPSCs have the distinct advantage that they
can be derived from somatic cells such as skin fibroblasts from
essentially any donor subject for reintroduction to that same
individual as an autologous transplant. They are advantageous for
the study of human disease because they are essentially ‘‘pre-
validated’’ and may be derived directly from individuals with
clinically confirmed illness[1,2].
Multiple studies have determined that IPSCs are very similar to
ESCs in their pluripotency and capacity to differentiate[3–5], and
more recent studies have sought to determine whether IPSCs and
their derivatives also show signs of cellular rejuvenation following
adoption of the ESC-like phenotype[6–10]. We have recently
described a matched set of cell lines derived from two fibroblast
(FIB) lines — FIBA and FIBB – designed to answer questions
regarding the ‘‘before and after’’ specifics of IPSC conversion[7].
Both FIBA and FIBB display average telomere lengths that are
approximately equivalent (10.25 Kb and 10.76 Kb respectively)
even though both lines were derived from individuals of very
different ages (EW16 and 70 yrs, respectively). This is likely due to
the relatively high growth rate and number of population
doublings that rendered FIBA comparable in cellular age to the
lower-passage and more recently-derived FIBB from an elderly
donor. Despite the fact that both lines were relatively old in
cellular terms, both yielded multiple IPSC lines displaying all of
the hallmarks of human ESCs, and displayed an average telomere
elongation of .40% (10.5 Kb to 15.4 Kb) compared to input
cells[7]. Together, these results suggested that reprogramming
restored at least one key indicator of cellular age – telomere length
– following adoption of the IPSC phenotype. In addition, unlike
mouse IPSCs where telomere elongation rivaling mESCs was not
observed until approximately passage 30[6], average human IPSC
telomere lengths equaled or exceeded average hESC telomere
lengths (15.4 Kb vs 13.9 Kb) by passage 5, the earliest time-point
examined. Recently, other groups have reported similar increases
in IPSC telomeres derived from other fibroblast lines[10].
Of equal importance to the observation that reprogramming to
pluripotency leads to telomere elongation, we also found that after
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shortening was resumed in IPSC-derived cells. Since telomeres
only shorten at a rate of approximately 50–100 bp/replicative
cycle[11–14], in order to observe measurable telomere decreases
in IPSC-derived cells, we elected to establish and analyze
fibroblast lines derived from IPSC teratomas to better mimic the
degree of growth and differentiation that may be incurred during
normal human development. In the majority of teratoma-derived
fibroblast lines (referred to as TER lines), the combined number of
replicative cycles required for teratoma growth and the subsequent
production and expansion of homogenous TER lines produced a
dramatic loss of telomere length (from an IPSC average of
15.4 Kb to a TER average of 10.4 Kb)[7]. This result, coupled
with morphologic observations, immunocytochemical indicators,
and genome-wide methylation analysis confirmed that TER cells
were differentiated fibroblastic cells that had resumed normal
cellular aging following loss of pluripotency. While this result
suggested that IPSC-derived cells regained the capacity for many
population doublings as the result of conversion to an ESC-like
state (50–100 added doublings, assuming that each kilobase of
telomere translates into 10–20 added cycles), these results could
give no indications regarding the overall robustness or ‘‘energet-
ics’’ of the derived cells. A better understanding of the rejuvenative
state of IPSC-derived cells is important for at least two reasons.
First, if after the derivation process, the resulting cells have
substantially longer life but retain the cellular properties of a
relatively old donor cell, then donor age is an important
consideration in future cell replacement therapies, whereas, if
IPSC-derived cells not only can live longer, but also take on the
robust energetic properties of youthful cells, cellular replacement
from donors of any age would be predicted to have equal positive
potential.
The second reason that an understanding of the functional
‘‘age’’ of IPSC-derived cells is important relates to the burgeoning
use of IPSCs to study human disease. Results from our laboratory
and others suggest that the quality and cellular age (as measured
by telomere length) of IPSCs derived from young and old subjects
are essentially equivalent; however, as more and more differen-
tiated cell models derived from donor subjects of disparate ages
become available, it becomes important to know whether, and to
what extent, observed differences may be influenced by donor age.
If IPSC-derived cells are capable of more cell divisions, but in
other respects ‘‘behave’’ like cells of the donor age, this suggests
that age-matching will be critical to establishment of useful model
cell lines, whereas if IPSC conversion rejuvenates both cell cycle
capacity and other cellular properties, then cross-comparisons of
IPSC-derived cultures without concern for donor age would be
reasonable, but the use of IPSC-derived cultures from elderly
donors with the expectation of modeling ‘‘aged’’ cell types would
not be valid in most instances.
One measurement of cellular health and energetics that
correlates with both cellular and organismal age is mitochondrial
function[15–17]. In mammals, all mitochondria are maternally
derived from the oocyte. A high-quality oocyte mitochondrial
complement is critical to provide the best possible start for the
generation of a completely new individual[18]. While oocyte
mitochondria are robust, shortly after fertilization the mitochon-
drial complement is diluted by cell division and becomes much less
active, in part because of the low-oxygen environment without
direct access to the blood supply, but also because mitochondrial
activity and oxidative phosphorylation (OXPHOS) create reactive
oxygen species (ROS) as a by-product that can damage DNA and
introduce mutations. DNA damage at the very earliest stages of
development giving rise to even small changes to the genome
could have catastrophic consequences as dividing cells are
propagated throughout the developing organism, hence, the
mitochondrial complement of ESCs in situ is both small and of
low activity[18–20].
With the establishment of differentiation in the developing
embryo, the mitochondrial complement both diversifies and
amplifies depending on the cell type. Typically, somatic cell types
such as newly-derived embryonic fibroblasts have efficient
mitochondrial complements and abundant ATP, and as they age
(either in situ or in vitro), accumulate larger proportions of
mitochondria in increasingly active configurations in an effort to
keep up with energetic demands. Cell types such as CNS neurons,
skeletal, and heart muscle adopt complex mitochondria configured
for maximal respiration and ATP production. The impact of age
on mitochondrial function in these tissues is evidenced by the
progressive nature of neuropathies and myopathies in patients
with mitochondria compromised by disease [21].
To better understand the relationship between cellular identity,
cellular age, and their impact on mitochondria, two recent reports
have compared several properties of the mitochondrial comple-
ment of input fibroblasts, IPSCs, and IPSCs allowed to
differentiate for several weeks in culture[22,23]. Their results
indicate that like ES cells, IPSCs display reduced ROS production
that stems from a mitochondrial complement reduced in number
and mass from the level in input cells to a level similar to hESCs.
Analysis of differentiating IPSC cultures revealed that, for the most
part, mitochondrial properties returned to the pre-reprogrammed
state similar to input fibroblasts following several weeks of
differentation.
Together, these results suggested that although the IPSC
conversion process resets the biological clock, other important
measures of cell fitness such as mitochondrial function, is either
not improved or is even slightly compromised compared to input
cells.
We have analyzed the structural and functional properties of
mitochondria in the FIB, IPSC, TER, and ESC lines character-
ized for telomere elongation and found substantial differences in
the TER mitochondrial complement derived after long-term
growth and differentiation. Our results confirm that IPSCs display
mitochondria very similar to their natural ESC counterparts, but
that after redifferentiation the mitochondrial complement has
undergone a dramatic functional improvement compared to both
IPSCs and parental fibroblast lines. Our results indicate that IPSC
conversion resets not only the replicative — but also the energetic —
capacity of derived cells, suggesting that even tissues from elderly
individuals can be restored to a biological age functionally
equivalent to new-born cells.
Results
Mitochondria were analyzed in two human primary cell lines at
three phenotypic stages: fibroblasts, IPSCs, and fibroblasts derived
from IPSC teratomas. Two lines of human ESC were also
analyzed for comparsion to IPSCs. The fibroblast cell lines —
FIBA and FIBB — used in these analyses have been described
previously[7], and were selected because at all stages of
differentiation they appeared very similar to other cell lines used
for analysis of pluripotency[3,4]. Furthermore, despite the fact that
both lines were derived from donors of disparate ages, they
displayed signs of cellular aging with telomeres of similar
lengths[7] as discussed in the Introduction. The IPSC lines A
and B (derived from fibroblast lines A and B), also displayed very
similar morphologies, marker expression, global methylation
profiles, capacity for teratoma formation, and telomere elonga-
IPSC Human Aging
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differentiated fibroblast-like lines (TER lines) were produced from
explants of IPSCA and B teratomas, expanded in vitro, and
selected over multiple passages for cells of fibroblast morphology.
TER cells appear morphologically similar to FIB cells with a small
nucleus/cytoplasm ratio and a flattened stellate shape distinctly
different from IPSCs (Fig. 1A–C). In addition to morphology,
TER cells also resembled the input fibroblasts lines and differed
dramatically from IPSCs in methylation profile and telomere
shortening [7], and in the expression of multiple markers by both
qPCR and immunocytochemical analysis (Fig. 1D–E). In addition
to indirect indicators — such as the functionality of human-specific
reagents in methylation and qPCR analysis – the human origin of
TER cells was further confirmed by positive immunostaining for
human-specific nuclear antigen (Fig. 1.A,C). Although no IPSC-
derived cell is likely to be phenotypically identical to the parental
input cell, we believe that TER cells represent the best
approximation possible.
For functional analyses, four mitochondrial properties were
measured for each cell type: 1) total cellular ATP, 2) ADP/ATP
ratio, 3) mitochondrial mass, and 4) mitochondrial membrane
potential, to determine if general mitochondria performance
changed with dedifferentiation and redifferentiation and if direct
reprogramming to the IPSC phenotype produced mitochondria
functionally similar to the mitochondrial complement of human
ESCs as previously reported[22,23]. Previous studies [7] and
ongoing experiments revealed few, if any, differences among cell
lines within a type, so to increase the confidence of our analysis
given the limited number of subjects available, the data were
analyzed using a least-squares ANOVA with cell line effects nested
within cell type.
Measurement of cellular ATP was performed using a luciferase
bioluminescence assay and the results are shown in Fig. 2A. Of the
four cell types, TER cells displayed the highest cellular ATP
content (32.84 fmol/cell) and differed significantly from both
IPSCs and ESCs. IPSCs and ESCs displayed similar and low ATP
levels (9.40 and 9.49 fmol/cell, respectively), while input FIB cells
displayed ATP levels in the mid-range (14.21 fmol ATP/cell),
closer to the pluripotent cell types than to TER cells.
Determination of the ADP/ATP ratio, a general indicator of
cell metabolism, indicated that although TER cells displayed
higher total cellular ATP than all of the other cell types, the
relative ratio of ADP to ATP in TER cells was similar to the ADP/
ATP ratio observed in parental fibroblasts (2.8 and 4.3,
respectively) (Fig. 2.B). The ADP/ATP ratio for the differentiated
cell types differed substantially from the ADP/ATP ratios in the
pluripotent cell types (15.0 for ESCs and 18.8 for IPSCs).
The experiment shown in Fig. 2B suggested that overall
metabolic activity as measured by the ADP/ATP ratio segregated
along phenotypic lines; however, the overall higher ATP level seen
in the TER cells in Fig. 2A remained unexplained. We reasoned
that one explanation for this discrepancy might be a substantial
difference in mitochondrial mass between TER cells and other cell
types. Mitochondrial mass was assessed by NOA staining (Fig. 2C),
and revealed that the mitochondrial mass of TER cells did not
differ significantly from either IPSCs or ESCs. Only FIB cells
displayed a significant difference in mitochondrial mass, with an
approximate 2-fold increase over the other cell types. Far from
explaining the elevated level of ATP in TER cells, indications that
FIBs bore a larger mitochondrial complement than TER cells
argued that FIB/TER differences were likely to reflect some form
of improvement in mitochondrial quality as opposed to quantity.
Mitochondrial membrane potentials of all cell types were
analyzed using flow cytometry and the vital dye JC-1[24] to
further study the mitochondrial complement. These analyses
shown in representative scatter plots in Figure 3A, indicate at a
Figure 1. Morphological characteristics and marker expression of FIB, IPSC, and TER cells. FIBA and derivatives are used as examples.
A–C) Phase-contrast images showing the morphology of FIB, IPSC, and TER lines as labeled. Insets in A and C show reactivity of FIBA and TERA with
human-specific nuclear (HuNu) antigen antibody (green). Blue is DAPI co-stained DNA. D) Graphical representation of the relative expression of
pluripotency-related gene mRNAs in all cell lines (IPSC value set at 100%). Pluripotency marker genes were detected at low levels in FIB and TER cells
compared to IPSCs. E–F) Immunocytochemical analysis of IPSCs (E) and TER cells (F), indicating that TER cells had not only lost high-level of
expression of pluripotency markers such as Nanog, but also gained expression of fibroblasts markers such as fibronectin (FBN) (see also Ref. 7).
Magnification: 800X, insets 250X.
doi:10.1371/journal.pone.0014095.g001
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the ratio of red-to-green differential fluorescence. Mitochondria
with high membrane potential and a more active electron
transport chain efficiently imported the JC-1 dye resulting in
aggregation and red JC-1 fluorescence (delineated as region 4(R4)
in the plots in Fig. 3A), whereas in less active mitochondria with
lower membrane potential, the JC-1 remains in the monomeric,
green-fluorescent conformation (region R3 in Fig. 3A). Quantifi-
cation of the relative ratios are shown in Fig. 3B. Whereas FIB,
IPSC, and ESC lines displayed R/G ratios between 1.1–1.9, the
TER lines displayed an average R/G ratio of 41.8. This further
indicated that the TER cell mitochondrial complement differed
significantly from the input parental fibroblasts as well as the
pluripotent cell types.
To explore the underpinnings of increased TER cell mitochon-
drial efficiency, we employed electron microscopy and the
advanced 3D technique of electron tomography (ET) to examine
and quantify ultrastructural characteristics of the mitochondria in
each cell type. Three-dimensional ultrastructural analysis can
determine the overall disposition and complexity of individual
mitochondrial crista and matrix – compartments formed by the
inner mitochondrial membrane — that play a critical role in
multiple mitochondrial functions including calcium storage,
glutamate production, and most importantly, the efficient
generation of ATP. ET was used to assess the complexity of
mitochondrial architecture (Figure 4A–C). In the top panels of
Figs. 4A–C, central slices through tomographic volumes of
mitochondria illustrate the range of mitochondrial configurations
observed in the cell lines analyzed. In the lower panels,
reconstructions producing top- and side-views of surface-rendered
volumes that facilitate visualization of the disposition and
complexity of individual cristae (false colored) are shown. The
upper panel of Figure 4A shows a mitochondrion with steady-state
morphology known as the orthodox configuration, characterized in
cross-section by tightly packed thin cristae filling an expanded,
more translucent mitochondrial matrix. The reconstructions in the
lower panels reveal a correspondingly complex cristae comple-
ment.
Figure 4B, on the other hand, shows a mitochondrial morpho-
logy referred to as the condensed configuration, and is characterized
by mitochondria with a dark, condensed matrix and thus
expanded, translucent cristae. Mitochondria can interconvert
between the broadly defined orthodox and condensed configura-
tions [25]. The complexity of cristae in mitochondria of the
condensed configuration is manifest using a 3D technique such as
ET. There are generally fewer and larger cristae in the condensed
organelle, as displayed in the reconstructions in the lower panel of
Fig. 4B, indicating that cristae remodeling needs to occur upon
transition from the orthodox to the condensed conformation. An
extreme of the condensed configuration is the ultracondensed
configuration (Fig. 4C). The matrix of ultracondensed mitochon-
dria appear as dense bodies, described as ‘sausages’ that snake
through the mitochondrial interior, are often interconnected, and
surround a single or small number of greatly expanded cristae
where the crista junctions have been enlarged to several-times
normal [26]. As shown in the tomographic reconstructions,
ultracondensed mitochondria display complex topology of their
crista architecture (Fig. 4C, lower panels).
Transmission electron microscope images (TEMI) from each
cell type were examined to determine the morphological
disposition of mitochondria. Representative images of FIB
(Fig. 4D,E), IPSC (Fig. 4F,G), TER (Fig. 4H,I) and ESC lines
(Fig. 4J,K) showed an apparent high degree of similarity among
FIB, IPS, and ESC mitochondria, and a distinct difference in the
morphology of TER mitochondria. To quantify these potential
differences, mitochondria in a series of TEMI from each cell line
were counted and assigned to one of two broad categories:
orthodox or condensed.
The ratio of mitochondria in the orthodox configuration
compared to condensed conformation is shown in Figure 4L. As
suggested by the representative images of Fig. 4D–K, the FIB, IPS,
and ESC lines displayed mitochondrial complements composed
predominantly of mitochondria in a condensed configuration,
whereas TER cells lines displayed an overwhelming preponder-
ance of mitochondria in an orthodox configuration (Fig. 4L).
Discussion
Our study examines the disposition of the mitochondrial pool in
reprogrammed cells at three phenotypic stages: pre-reprogram-
ming, after forced de-differentiation and assumption of a
pluripotent identity, and after re-differentiation to a phenotype
similar to the input cell.
Figure 2. Functional comparison of mitochondria in FIB, IPSC,
TER and ESCs. A) Total cellular ATP (fmoles/cell) in each cell type as
labeled. B) ADP/ATP ratio in each cell type as labeled. C) Relative
mitochondrial mass in tested cell types. Error bars indicate SEM. Letters
above individual bars indicate values that differ statistically (P,0.05)
from other cell type(s). (FIB=F, IPS=I, TER=T, ESC=E).
doi:10.1371/journal.pone.0014095.g002
IPSC Human Aging
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mitochondrial complement that, in most respects, does not differ
significantly from the mitochondrial complement of natural
human ESCs. Together, these findings suggest that the nuclear
program of cells identifying themselves as ‘‘pluripotent’’ actively
promotes a smaller and less active mitochondrial complement —
presumably to minimize the potential for DNA damage from ROS
— as suggested in the Introduction. Data directly examining ROS
and the expression of factors that modulate DNA integrity in
IPSCs further confirms this notion [22,23].
A comparison of mitochondrial morphologies in IPSCs and
ESCs using TEM by Prigione et al. [23] found that both cell types
had a number of mitochondria with ‘‘underdeveloped crista’’ and
an ‘‘immature-like morphology characteristic of ESCs’’. We
observed a similar morphology in IPSC and ESC mitochondria
that we interpreted more as a ‘‘condensed’’ configuration than
underdevelopment; however, both properties might contribute to
the morphological appearance. IPSC/ESCs represent an unusual
cellular state – one in which the biological program is prepared for
an in vivo environment that is oxygen deprived (prior to
implantation and establishment of a blood supply), but instead
finds itself in the oxygen-rich environment of a cell culture
incubator. For this reason, the relationship between mitochondrial
structure and function that is well established in somatic cells (see
below) may not apply to pluripotent cell types maintained in vitro.
What is certain, however, is that IPSC and ESC mitochondria are
very similar to each other, and all indications are that both cell
types have low oxidative phosphorylation and ROS generation,
producing in an intracellular environment conducive to the
preservation of genomic integrity.
A more pressing question with regard to the practical uses and
applications of IPS cells, however, is the relative fitness of the
downstream derivatives of IPSCs that can be used to study healthy
or diseased human tissues, or, one day, as potential sources for
cellular replacement therapy. Although our earlier study docu-
ments telomere elongation after reprogramming to pluripotency
Figure 3. Analysis of mitochondrial membrane potential in FIB, IPSC, TER and ESCs. A) Representative scatter plots from flow cytometry
analysis showing red/green JC1 dye fluorescence in cell types as labeled. The outlined area R4 is red fluorescence and area R3 is green fluorescence.
B) Bar graph showing the ratio of JC-1 red and green (R/G) fluorescence indicative of mitochondrial membrane potential for each cell type. Error bars
indicate SEM. Letters above individual bars indicate values that differ statistically (P,0.05) from other cell type(s). (FIB=F, IPS=I, TER=T, ESC=E).
doi:10.1371/journal.pone.0014095.g003
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PLoS ONE | www.plosone.org 5 November 2010 | Volume 5 | Issue 11 | e14095Figure 4. Structural comparison of mitochondria in FIB, IPS, TER, and ESC cell types. A–C) Electron tomography of the mitochondrial
configurations observed. Three primary configurations were observed: A) top panel: A central slice through a tomographic volume showing the
orthodox configuration. bottom panel: Top and side views of the segmented and surface-rendered volume of the orthodox mitochondrion showing
individual cristae in various colors (top view (upper) side view (lower)). B) As in A, for the condensed configuration. C) As in A,B for the ultracondensed
configuration. Arrowheads point to greatly enlarged crista junctions. D–K) Representative TEMI of mitochondria in all cell lines. (Mag=7500-10000X).
FIB and IPSC lines displayed a mix of mitochondrial configuration, most of condensed configuration (FIBA (D), FIBB (E), IPSCA (F), IPSCB (G)). TER cells
displayed a preponderance of orthodox mitochondria (TERA (H), TERB (I)), and native ESCs displayed a preponderance of condensed mitochondrial
forms (ESCA (J), ESCB (K)). L) Bar graph of the ratio of mitochondria scored as orthodox or condensed configuration (O/C) in FIB, IPS, TER, and ESC cell
types as labeled. Error bars = SEM. Letters above TER bar indicate statistical difference (P,0.03) from all three other cell types.
doi:10.1371/journal.pone.0014095.g004
IPSC Human Aging
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neither this earlier report, nor others published since, provide
indications as to whether or not the energetic of the intracellular
environment of re-differentiated cells are altered to match the
renewal of cellular longevity.
We observed a dramatic increase in cellular respiration in TER
cells compared to parental fibroblasts that has not been described
previously. This improvement was marked by increases in cellular
ATP, mitochondrial membrane potential, and the number of
mitochondria of orthodox configuration. We postulate that the
compromised mitochondria observed in the FIB cells arose as the
result of multiple stressors that accompany advanced cellular age
and the approach of senescence — such as ROS damage and
increased cell death – that are known to impact mitochondrial
configuration and function [27–31]. If the condensed and
ultracondensed mitochondrial configurations seen in FIB cells
are considered indicative of an effort to maximize ATP production
[25,26] as compensation for cellular dysfunction (brought on by
the aging process), then mitochondria in the orthodox configura-
tion observed in TER cells may be thought of as a capacitor, fully
charged and ready to work in the production of ATP within an
environment with sufficient ATP for cellular needs. In short, the
likely source of significantly increased membrane potential and
ATP production in the TER cells arises from the substantial
increase in healthy, orthodox configuration mitochondria with
high metabolic capacity.
It is likely that the impact of reprogramming on mitochondria
was evident in our experiments and not in two other recent reports
[22,23] because the cells we used carried a relatively compromised
mitochondrial complement discussed above. As a consequence,
improvements in mitochondrial function that were readily
observed in our experiments would probably not be seen in
energetically robust cell lines such as those described in other
reports.
Another difference in the experimental paradigm that we used
was the derivation of differentiated cells from teratoma tissue as
opposed to derivation from cells differentiated exclusively in vitro.
The original objective of this method of obtaining IPSC-derived
lines was to push differentiation and replicative cycles to an
extreme that would allow us to observe shortened telomeres and
the resumption of normal aging to a degree that was measurable
by TRF analysis, as previously reported for the TER lines used
herein[7]. Another possible explanation for the differences
observed between input cells and IPSC-derived cells in this report
compared to earlier reports is that TER cells may be more
differentiated, more homogenous, and more ‘‘fibroblastic’’ than
cells generated by short-term differentiation in vitro. Even though
cellular morphology and the nuclear program undergo a change
after a few population doublings and within the relatively short
time-frame of a few weeks, it may be that the mitochondrial
complement requires more time and replicative cycles to realize its
full potential. Future studies will determine whether extension of in
vitro differentiation to longer periods will result in mitochondrial
improvements similar to those we observed in TER cells.
Another possibility that cannot be ruled out is that the teratoma
growth process, which accounts for the vast majority of the
replicative cycles the TER lines undergo, also entails a selective
process that weeds out energetically inferior cells producing a
population of IPSC-derived ‘‘super cells’’. Regardless of whether
the changes we observe between FIB and TER cells is a simple
function of input cell robustness, differentiation paradigm, or
selection for super cells by many population doublings, our results
unequivocally indicate that the derivatives of IPSC lines that have
undergone telomere elongation and subsequent resumption of
apparently normal aging after differentiation, can possess a
mitochondrial complement that displays substantial improvements
and indications of cellular rejuvenation in parallel.
It remains to be seen if these results raise new concerns with
regard to the eventual use of IPSC derivatives for therapeutic
transplants. If in vitro methods are not forthcoming, and growth
and differentiation within a living animal host is required to
‘‘reset’’ the mitochondria of cells derived from donors with
compromised mitochondrial pools (i.e. from age or disease), then it
is possible that only IPSCs derived from sources or cell types with
robust mitochondrial pools will be suitable to generate good
transplant material for some tissue types such as differentiated
neurons. On the other hand, these data suggest that IPSC-derived
stem cell populations — such as bone marrow, liver, muscle, or
skin progenitors – produced from sources with essentially any
quality of mitochondria could, over time, improve and maximize
their mitochondrial pool following engraftment. In either event,
these results suggest that changes in the mitochondria of




The origin, derivation, and conditions of culture, and
characterization of the fibroblast, IPSC, and TER cell lines used
in this report have been reported previously [7]. FIBA and FIBB
are described therein, IPSCA and IPSCB of this report correspond
to line IPSCA3 and IPSCB3, and TERA and TERB correspond
to lines TERA3 and TERB3. Line ESC1 in this report is human
ESC line H9 and ESC2 is H1 (WiCell Research Institute,
Madison, WI). Cell lines were analyzed at passages used in [7],
except line ESC2 (H1) which was used at passage 26–28.
Expression analysis
Phase-contrast imaging, qPCR analysis, and immunocytochem-
istry was performed were as described [7]. HuNu antibody
MAB1281 (Chemicon/Millipore, Billerica, MA) was used at
1:250, and others as in Ref. 7.
Measurement of cellular ATP and ADP/ATP ratios
Determination of cellular ATP concentrations was performed
using an ATP Bioluminescent Somatic Cell Assay Kit (Sigma,
Saint Louis, MO, USA) as previously described[32]. Briefly,
duplicate luminometer readings were taken from each sample
over 20 s intervals, and the average relative light unit readings
were used to determine ATP content in the samples against
the standard curve. ADP/ATP ratios were determined using
the EnzyLight
TM ADP/ATP ratio assay kit from BioAssay
Systems (Hayward, CA, USA) according to the manufacturer’s
instructions.
Assessment of MMP and Mitochondrial Mass
Evaluation of mitochondrial membrane potential and assess-
ment of mitochondrial mass were performed as previously
described [24]. The cell concentration in stained samples was
adjusted to 1610
6 cells/ml. The cells were stained using the
membrane-sensitive dye JC-1 (DePsipher
TM; R&D Systems,
Minneapolis, MN, USA) or nonyl acridine orange (Molecular
Probes, Inc., Eugene, OR, USA), and then analyzed by flow
cytometry (BD Vantage SE) using a 520-nm filter for the
observation of the green fluorescence and 590 nm for the red
fluorescence.
IPSC Human Aging
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quantification of mitochondrial/crista properties
EM analysis of mitochondria was as previously de-
scribed[32,33]. Briefly, three-dimensional reconstructions of
portions of the cell containing mitochondria were generated using
standard techniques[34]. Sections with a thickness about 500 nm
were cut out, and stained for 30 min in 2% aqueous uranyl
acetate, followed by 15 min in lead salts. Next, fiducial cues
consisting of 15 or 20 nm colloidal gold particles were deposited
on either side of each section.
For each reconstruction, a series of images at regular tilt
increments were collected with a JEOL 4000EX intermediate-
voltage electron microscope operated at 400 kV. Tilt series were
recorded at a magnification of 12,000X with an angular increment
of 2u from 260u to +60u about an axis perpendicular to the optical
axis of the microscope using a computer-controlled goniometer to
achieve accurate increments at each angular step. Illumination was
held to near parallel beam conditions and optical density
maintained constant by varying the exposure time. Images were
collected using a slow-scan CCD camera with 409664096 pixels
at a resolution of 0.71 nm per pixel. The IMOD package[35] was
used for generating the reconstructions. Volume segmentation was
performed by manual tracing in the planes of highest resolution
with the program Xvoxtrace[36,37]. Mitochondrial reconstruc-
tions were visualized using Analyze (Mayo Foundation, Rochester,
Minnesota). Segmented and surface-rendered volumes were
examined with Synu (National Center for Microscopy and
Imaging Research), as described[38]. These programs allow one
to step through reconstructed slices in any orientation and to track
or model features of interest in three dimensions. Measurements of
structural features were made within segmented volumes by the
programs, Synuarea and Synuvolume (National Center for
Microscopy and Imaging Research). Quantification of the
presence of different mitochondrial structures was performed on
random transmission EM-acquired images.
Quantification of mitochondrial configuration in each cell line
was performed by manual counting of mitochondria of orthodox
or condensed configuration in 4–6 representative EM images (of
each line) by six unbiased volunteers unfamiliar with the study.
The volunteers were instructed as to the visual characteristics of
mitochondria of both general configurations at 5800-10000X
magnification, and were instructed to count only the mitochondria
where the crista disposition — and therefore the configuration —
could be definitively visualized for categorization. The results of
each count were converted to a ratio of orthodox/condensed
mitochondria and the averages and standard errors calculated.
Statistical analysis
Data were tested for normality using SAS statistical analysis
software (Cary, NC). Variables that did not present normal
distribution were transformed by log(10) and re-analyzed. Results
are presented as untransformed data for ease of understanding.
Discrete variables were analyzed by least squares ANOVA, using
the GLM procedure of the SAS software with cell type and cell
line set as independent variables. The effect of cell line was nested
within cell type.
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